Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical development. Its structure supports the creation of enzyme inhibitors and receptor modulators, making it valuable in drug discovery for metabolic and central nervous system disorders. The difluoromethyl group enhances metabolic stability and binding affinity, improving drug efficacy. Commonly employed in the preparation of antidiabetic agents and neuroactive therapeutics due to its favorable pharmacokinetic properties.